Company Data

Cyclo Therapeutics Inc.

Ticker
CYTH
Current Price
$0.7206
Market Cap
$20.7M
Price Target
Refer to Report
Volume
5.5K
52wk Range
$0.55 - $1.79
Advanced Market Data

Overview

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy